Ovarian cancer survival statistics

Survival

Survive ovarian cancer for 10 or more years, 2010-11, England and Wales

Age

Age that ovarian cancer survival is highest, 2009-2013, England

 

Improvement

Ovarian cancer survival in the UK has almost doubled in the last 40 years

72% of women survive ovarian cancer for at least one year, and this is predicted to fall to 46% surviving for five years or more, as shown by age-standardised Open a glossary item net survival for patients diagnosed with ovarian cancer during 2010-2011 in England and Wales.[1]

Ovarian Cancer (C56 and C57.0-C57.7), Age-Standardised One-, Five- and Ten-Year Net Survival, Women (Aged 15-99), England and Wales, 2010-2011

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Women Net Survival 72.4 46.2 34.5
95% LCL 72.4 45.9 33.8
95% UCL 72.5 46.4 35.3

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item

Five- and ten-year survival is predicted using an excess hazard statistical model

Ovarian cancer survival continues to fall beyond five years after diagnosis. 35% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with ovarian cancer during 2010-2011 in England and Wales.[1] Out of 20 common cancers in England and Wales, ten-year survival for ovarian cancer ranks 7th lowest (both overall and for females only).

Ovarian Cancer (C56 and C57.0-C57.7), Net Survival up to Ten Years after Diagnosis, Women (Aged 15-99), England and Wales, 2010-2011

Survival for ovarian cancer is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

See also

Cancer survival statistics for common cancers in the UK

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014. 
  2. ISD Scotland. Trends in Cancer Survival 1983-2007. 
  3. Northern Ireland Cancer Registry. Incidence & Survival 1993-2012.

About this data

Data is for: England and Wales, 2010-2011, ICD-10 C56 and C57.0-C57.7

Last reviewed:

Five-year survival for ovarian cancer is highest in the youngest women and decreases with increasing age. Five-year net survival ranges from 87% in 15-39 year-olds to 20% in 80-99 year-olds for patients diagnosed with ovarian cancer in England during 2009-2013.[1]

Ovarian Cancer (C56 and C57.0-C57.7), Five-Year Net Survival by Age, Women, England, 2009-2013

See also

Ovarian cancer incidence statistics by age

Ovarian cancer mortality statistics by age

Cancer survival statistics by age for all cancers in the UK

References

  1. Office for National Statistics. Cancer survival in England: adults diagnosed in 2009 to 2013, followed up to 2014. Newport: ONS; 2015.

About this data

Data is for: England, 2009-2013, ICD-10 C56 and C57.0-C57.7

Last reviewed:

As with most cancers, survival for ovarian cancer is improving. One-year age-standardised Open a glossary item net survival has increased from 44% during 1971-1972 to 72% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 29 percentage points.[1] Much of this increase can be attributed to the greater use of platinum-based chemotherapy.[2]

Ovarian Cancer (C56 and C57.0-C57.7), Age-Standardised One-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Five-year age-standardised net survival for ovarian cancer has increased from 21% during 1971-1972 to a predicted survival of 46% during 2010-2011 in England and Wales – an absolute survival difference of 26 percentage points.[1] Wider access to optimal primary treatment and greater determination to treat recurrent disease is likely to have contributed to the increase.[2]

Ovarian Cancer (C56 and C57.0-C57.7), Age-Standardised Five-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted  using an excess hazard statistical model

Ten-year survival has increased by a lesser amount than one- and five-year survival since the early 1970s. Ten-year age-standardised net survival for ovarian cancer has increased from 18% during 1971-1972 to a predicted survival of 35% during 2010-2011 in England and Wales – an absolute survival difference of 16 percentage points.[1] Overall, more than a third of women diagnosed with ovarian cancer today are predicted to survive their disease for at least ten years.

Ovarian Cancer (C56 and C57.0-C57.7), Age-Standardised Ten-Year Net Survival, Women (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

See also

Ovarian cancer incidence trends over time

Ovarian cancer mortality trends over time

Cancer survival statistics for common cancers in the UK

References

  1. Data were provided by London School of Hygiene and Tropical  Medicine on request, 2014.
  2. Kitchener HC. Survival from cancer of the ovary in England and Wales up to  2001. Br J Cancer 2008;99 Suppl 1:S73-4.

About this data

Data is for: England and Wales, 1971-2011, ICD-10 C56 and C57.0-C57.7

Last reviewed:

Survival for ovarian cancer is strongly related to the stage of the disease at diagnosis.

One-year net survival for ovarian cancer is highest for patients diagnosed at stage I, and lowest for those diagnosed at stage IV, 2014 data for England show.[1] 99% of patients diagnosed at stage I survived their disease for at least one year, versus 51% patients diagnosed at stage IV.[1]

One-year net survival for unknown stage ovrian cancer is 46%. Lack of staging information may in some cases reflect advanced stage at diagnosis: for example very unwell patients may not undergo staging tests if the invasiveness of the testing outweighs the potential benefit of obtaining stage information.[1]

Ovarian Cancer (C56-C57), One-Year Age Standardised Net Survival by Stage, Adults (Ages 15-99 Years), England 2014

One-year relative survival is similar between women living in the most and least deprived areas, at all stages, 2012 data for England show.[2]

Five-year survival for ovarian cancer shows a much more rapid decrease in survival between Stages I and IV. Five-year relative survival ranges from 90% at Stage I to 4% at Stage IV for patients diagnosed during 2002-2006 in the former Anglia Cancer Network.[3]

Ovarian Cancer (C56), Five-Year Relative Survival by Stage, Women (Aged 15-99 Years), Former Anglia Cancer Network, 2002-2006

See also

View our patient information on staging for bowel cancer

Ovarian cancer incidence by stage at diagnosis

Implications of staging data

References

  1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2016.
  2. National Cancer Intelligence Network. Stage Breakdown by CCG 2013. London: NCIN; 2015.
  3. Data were provided by The National Cancer Registration  Service, Eastern Office on request. Similar data can be found here: http://www.ncras.nhs.uk/ncrs-east/

About this data

Data is for: England, 2014 (one-year), Former Anglia Cancer Network, 2002-2006 (five-year), ICD-10 C56-C57

Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Last reviewed:

Five-year relative survival for ovarian cancer in women in England (31%) is below the average for Europe (38%). Wales (32%), Scotland (34%) and Northern Ireland (32%) are also below the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 30% (Ireland) to 44% (Sweden).[1]

Ovarian Cancer (C56.9, C57.0-C57.4, C57.7), Age-Standardised Five-Year Relative Survival, Females (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

See also

Cancer diagnosis and treatment

Ovarian cancer incidence

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, ovary and uterine adnexa cancer (C57.7).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

We’re now on twitter.

Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.